PFF Corporate Committee 



Members of the pharmaceutical industry, specialty pharmacy, and other key groups involved in pulmonary fibrosis (PF) treatment will meet three times each year to discuss topics including but not limited to:

  • The current disease landscape,
  • Trial design and recruitment,
  • Joint research efforts and registries,
  • Funding efforts and resources,
  • Endpoints, and
  • Legislative efforts.

If you are interested in participating or have any questions, please contact us at